首页> 美国卫生研究院文献>The Journal of Neuroscience >In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease
【2h】

In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease

机译:亨廷顿病小鼠遗传模型中NMDA受体介导的兴奋性毒性的体内证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

N-methyl-d-aspartate receptor (NMDAR)-mediated excitotoxicity is implicated as a proximate cause of neurodegeneration in Huntington Disease (HD). This hypothesis has not been tested rigorously in vivo. NMDAR–NR2B subunits are a major NR2 subunit expressed by striatal medium spiny neurons that degenerate in HD. To test the excitotoxic hypothesis, we crossed a well validated murine genetic model of HD (Hdh(CAG)150) with a transgenic line overexpressing NMDAR–NR2B subunits. In the resulting double-mutant line, we show exacerbation of selective striatal neuron degeneration. This is the first direct in vivo evidence of NR2B–NMDAR-mediated excitotoxicity in the context of HD. Our results are consistent with previous suggestions that direct and/or indirect interactions of mutant huntingtin with NMDARs are a proximate cause of neurodegeneration in HD.
机译:N-甲基-d-天冬氨酸受体(NMDAR)介导的兴奋性毒性被认为是亨廷顿舞蹈病(HD)中神经退行性变的最直接原因。该假设尚未在体内进行严格测试。 NMDAR–NR2B亚基是由HD变性的纹状体中棘神经元表达的主要NR2亚基。为了检验兴奋性毒性假说,我们将一个经过充分验证的HD小鼠遗传模型(Hdh (CAG)150 )与一个过表达NMDAR–NR2B亚基的转基因品系进行了杂交。在产生的双突变系中,我们显示出选择性纹状体神经元变性的加剧。这是HD背景下NR2B–NMDAR介导的兴奋性毒性的第一个直接体内证据。我们的结果与以前的建议一致,即突变亨廷顿蛋白与NMDAR的直接和/或间接相互作用是HD神经变性的直接原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号